Efficacy of Amniotic Membrane Use in Chronic Wound Treatment

This study investigates the application of human amniotic membrane in chronic wound care, focusing on its efficacy in promoting tissue regeneration and reducing the need for surgical interventions.Chronic wounds, often associated with comorbidities such as diabetes and vascular diseases, present significant treatment challenges.Human amniotic membrane, an avascular structure rich in extracellular matrix components and growth factors, offers a promising solution due to its immunomodulatory and regenerative properties.The study includes seven patients treated with human amniotic membrane for chronic wounds at a specialized wound care unit.Treatments were conducted over one to two-week intervals, emphasizing the importance of sterile application and consistent follow-up.Outcomes demonstrated significant wound size reduction, accelerated granulation and epithelialization, and minimized need for complex surgeries.Patients with comorbidities particularly benefited, showing improved wound bed preparation for simpler reconstructive procedures.Despite the promising results, limitations such as small sample size and lack of a control group were noted.The findings align with existing literature but emphasize the need for standardized protocols and further large-scale, controlled studies.Overall, human amniotic membrane demonstrates potential as a cost-effective, innovative therapy in chronic wound management, bridging gaps between conservative and surgical approaches.